Академический Документы
Профессиональный Документы
Культура Документы
in elderly
Geriatric Medicine
that branch of internal medicine which deals
with the prevention, diagnosis and treatment
of diseases specific to old age.
Ageing is not a disease it is a
biological process which will affect
everyone
Ageing is a biological process which cannot be
stopped or reversed-
Proper care can lead to healthy ageing
AGE-ASSOCIATED CHANGES
BODY COMPOSITION
CARDIOPULMONARY
Decreased heart rate response
Decreased coronary reserve
Increased systolic blood pressure
Decreased maximal oxygen capacity
Decreased vital capacity
Decreased FEV1
Increased residual volume
Increased ventilation-perfusion mismatch
AGE-ASSOCIATED CHANGES
ENDOCRINE
Decreased GROWTH HORMONE, INSULIN
GROWTH FACTOR, CALCITONIN, RENIN,
ALDOSTERONE, DEHYDROEPI-ANDROSTERONE
(DHEA)
RENAL
Decreased CREATININE CLEARANCE
Decreased RENAL BLOOD FLOW
Decreased Maximal urine osmolality
AGE-ASSOCIATED CHANGES
SENSORY CHANGES
heart diseases;hypertension
cancers;
Diabetes, metabolic syndrome
strokes that attack the brain;
dementias that affects memory and thinking;
injuries;
loss of hearing and sight;
diabetes;
joint problems caused by arthritis;
bone diseases that cause bones to break easily
mental diseases, such as depression.
The iceberg phenomenon
The prevalence and severity of CAD increases with age in both men and women. A
significant number of people > 60 years have significant CAD with increasing
prevalence of LM or MVD.
Age related CV disorders
Also, B-blockers may produce (CNS) effects and CCBs, especially the
dihydropyridines, can produce edema which is more frequent in older
patient.
Treatment of AMI:
A) Thrombolytic therapy (tPA): in 1st 3hours of AMI
(except if there are peptic ulcer, bleeding tendency, severe
hypertension, recent surgery in the last 3months).
B) Full dose of anti-coagulants (Heparin): is often given to
patients with anterior MI because of the high risk of mural
thrombi formation.
C) Clopidogril (Plavix): 4tablets in 1st day, then one tablet
/ every day.
D) R/ of risk factors and complications.
E) In severe angina, PCI or bypass surgery in suitable
cases.
In summary, what to consider when approaching to the
older patient with CAD:
1. Morbidity and mortality in the elderly with CAD and CAD treated medically or
with revascularization increases with age, especially in patients older than age
75 years.
2. Special care must be taken regarding medications, dose, collateral effects,
drug interactions and interaction with other comorbidities.
3. Clinically recognized CAD or heart failure confer the greatest risk for cardiac
death and warrant aggressive secondary prevention strategies.
4. In STEMI patients
In hospitals where direct PCI can be performed rapidly by experienced
operators, PCI has an advantage over thrombolysis.
In hospitals without PCI capability reperfusion therapy with thrombolytic
should be considered, regarding thrombolytic drugs especially in very old
patients, streptokinase should be considered.
Avoid combinations of GP IIb/IIIa inhibitors with thrombolytics. In case of
low molecular heparins and thrombolytics, lower doses as recommended can
be used.
II) Heart failure
Heart Failure (Causes)
A) Systolic HF: B) Diastolic HF:
S3 gallop. S4 gallop.